{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:49:34Z","timestamp":1791521374877,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRC\/2007\/13"],"award-info":[{"award-number":["HRC\/2007\/13"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacl.2026.09.007","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:25:15Z","timestamp":1789662315000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fatty liver index and atherogenic risk determined by lipoprotein particle subclasses: A cross-sectional study of middle- to older-aged adults"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4453-8446","authenticated-orcid":false,"given":"Se\u00e1n R.","family":"Millar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4965-9792","authenticated-orcid":false,"given":"Ivan J.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4916-4463","authenticated-orcid":false,"given":"Catherine M.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.09.007_bib1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S2468-1253(26)00011-7","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 1990\u20132023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023","volume":"11","author":"Kim","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jacl.2026.09.007_bib2","article-title":"MASLD and cardiovascular disease: a state-of-the-art review","author":"Shafiq","year":"2026","journal-title":"Glob Cardiol"},{"key":"10.1016\/j.jacl.2026.09.007_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacl.2017.02.001","article-title":"Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: a focus on atherogenic dyslipidemia","volume":"11","author":"Amor","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.09.007_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013479","article-title":"Trajectories of lipids profile and incident cardiovascular disease risk: a longitudinal cohort study","volume":"8","author":"Dayimu","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2026.09.007_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00218","article-title":"HDL particle number and size as predictors of cardiovascular disease","volume":"6","author":"Kontush","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacl.2026.09.007_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-65100-2","article-title":"Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: the GENES study","volume":"10","author":"Duparc","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacl.2026.09.007_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2006.05.007","article-title":"LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"192","author":"Mora","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.09.007_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000131511.50734.44","article-title":"Atherogenic lipoprotein particles in atherosclerosis","volume":"109","author":"Carmena","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.09.007_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040829","article-title":"Small dense LDL: scientific background, clinical relevance, and recent evidence still a risk even with \u2018normal\u2019LDL-C levels","volume":"10","author":"Superko","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jacl.2026.09.007_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.atherosclerosis.2009.01.044","article-title":"HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study","volume":"206","author":"Arsenault","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.09.007_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/diabetes.52.2.453","article-title":"Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance","volume":"52","author":"Garvey","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2026.09.007_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-021-01526-5","article-title":"Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico","volume":"20","author":"Flores","year":"2021","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2026.09.007_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13105-023-00991-z","article-title":"Fatty liver index (FLI): more than a marker of hepatic steatosis","volume":"80","author":"Kaneva","year":"2024","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.jacl.2026.09.007_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jacl.2026.09.007_bib15","first-page":"1","article-title":"The fatty liver index (FLI) 15 years later: a reappraisal","volume":"1","author":"Lonardo","year":"2021","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.jacl.2026.09.007_bib16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/hepr.70063","article-title":"Metabolic health phenotypes among middle-to older-aged adults living with and without obesity: relationships with hepatic health indicators","volume":"56","author":"Dolan","year":"2026","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jacl.2026.09.007_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914651","article-title":"Fatty liver index (FLI) identifies not only individuals with liver steatosis but also at high cardiometabolic risk","volume":"24","author":"Carli","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2026.09.007_bib18","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","article-title":"Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile","volume":"13","author":"Siddiqui","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacl.2026.09.007_bib19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/ije\/dys131","article-title":"Cohort profile: the Cork and Kerry diabetes and heart disease study","volume":"42","author":"Kearney","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacl.2026.09.007_bib20","article-title":"Primary care research: patient registration","volume":"95","author":"Hinchion","year":"2002","journal-title":"Ir Med J"},{"key":"10.1016\/j.jacl.2026.09.007_bib21","article-title":"Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study","volume":"5","author":"Khaw","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacl.2026.09.007_bib22","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jacl.2026.09.007_bib23","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/ije\/26.suppl_1.S161","article-title":"The Malm\u00f6 food study: validity of two dietary assessment methods for measuring nutrient intake","volume":"26","author":"Riboli","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacl.2026.09.007_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/26.suppl_1.S137","article-title":"Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers","volume":"26","author":"Bingham","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacl.2026.09.007_bib25","article-title":"Validation of a food frequency questionnaire as a tool for assessing nutrient intake","author":"Harrington","year":"1997","journal-title":"NUI Galway"},{"key":"10.1016\/j.jacl.2026.09.007_bib26","series-title":"SL\u00c1N 2007: Survey of Lifestyle, Attitudes and Nutrition in Ireland. Dietary Habits of the Irish Population","author":"Harrington","year":"2008"},{"key":"10.1016\/j.jacl.2026.09.007_bib27","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ajh\/hpt106","article-title":"DASH diet score and distribution of blood pressure in middle-aged men and women","volume":"26","author":"Harrington","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacl.2026.09.007_bib28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.jacl.2026.09.007_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117190","article-title":"Plant-based diet indices and lipoprotein particle subclass profiles: a cross-sectional analysis of middle- to older-aged adults","volume":"380","author":"Elliott","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.09.007_bib30","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1373\/clinchem.2018.288746","article-title":"Comparability of lipoprotein particle number concentrations across ES-DMA NMR, LC-MS\/MS, immunonephelometry, and VAP: in search of a candidate reference measurement procedure for apoB and non-HDL-P standardization","volume":"64","author":"Delatour","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2026.09.007_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/met.2014.0050","article-title":"Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance","volume":"12","author":"Shalaurova","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jacl.2026.09.007_bib32","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.2337\/dc13-S067","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2026.09.007_bib33","unstructured":"Clarke D., Romano J.P., Wolf M. The Romano-Wolf Multiple Hypothesis Correction in Stata. Available: https:\/\/www.iza.org\/publications\/dp\/12845\/the-romano-wolf-multiple-hypothesis-correction-in-stata."},{"key":"10.1016\/j.jacl.2026.09.007_bib34","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s10620-021-06954-y","article-title":"Fatty liver index and development of cardiovascular disease: findings from the UK biobank","volume":"66","author":"Zou","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jacl.2026.09.007_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076388","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","volume":"384","author":"Kim","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2026.09.007_bib36","doi-asserted-by":"crossref","first-page":"e1112","DOI":"10.1016\/j.hrthm.2025.12.029","article-title":"Fatty liver index increases the risk of sudden cardiac arrest in cardiovascular disease-free adults","volume":"23","author":"Li","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacl.2026.09.007_bib37","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/HYPERTENSIONAHA.124.24252","article-title":"Impact of NAFLD and fibrosis on adverse cardiovascular events in patients with hypertension","volume":"82","author":"Huang","year":"2025","journal-title":"Hypertension"},{"key":"10.1016\/j.jacl.2026.09.007_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf396","article-title":"Hepatic steatosis in cardiovascular\u2013kidney\u2013metabolic syndrome: fatty liver Index as a predictor of cardiovascular outcomes","author":"Kim","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2026.09.007_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00218","article-title":"HDL particle number and size as predictors of cardiovascular disease","volume":"6","author":"Kontush","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacl.2026.09.007_bib40","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in obesity: mechanisms and potential targets","volume":"5","author":"Klop","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.jacl.2026.09.007_bib41","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1210\/jc.2011-0690","article-title":"Hepatic VLDL overproduction: is hyperinsulinemia or insulin resistance the culprit?","volume":"96","author":"Gill","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2026.09.007_bib42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.metabol.2004.09.002","article-title":"Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the insulin resistance atherosclerosis study","volume":"54","author":"Goff","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2026.09.007_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-10-237","article-title":"A clustering analysis of lipoprotein diameters in the metabolic syndrome","volume":"10","author":"Frazier-Wood","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2026.09.007_bib44","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1042\/bst0311066","article-title":"Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein","volume":"31","author":"Packard","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jacl.2026.09.007_bib45","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1161\/01.ATV.20.9.2140","article-title":"The metabolic syndrome, LDL particle size, and atherosclerosis","volume":"20","author":"Hulthe","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2026.09.007_bib46","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2003-030636","article-title":"Low-density lipoprotein size and cardiovascular disease: a reappraisal","volume":"88","author":"Sacks","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2026.09.007_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.09.007_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-023-03578-0","article-title":"Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review","volume":"23","author":"Chary","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacl.2026.09.007_bib49","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/met.2014.0050","article-title":"Lipoprotein insulin resistance index: a lipoprotein particle\u2013derived measure of insulin resistance","volume":"12","author":"Shalaurova","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jacl.2026.09.007_bib50","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.amjmed.2024.03.033","article-title":"Lipoprotein insulin resistance score and mortality risk stratification in heart failure","volume":"137","author":"Turecamo","year":"2024","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2026.09.007_bib51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jamacardio.2020.7073","article-title":"Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women","volume":"6","author":"Dugani","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2026.09.007_bib52","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jacl.2015.03.010","article-title":"Low-and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease","volume":"9","author":"Sonmez","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.09.007_bib53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis","volume":"227","author":"DeFilippis","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.09.007_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120557","article-title":"Fatty liver-index, systemic inflammation and cardiovascular mortality. Results from the LURIC study","author":"Wissel","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.09.007_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202149641","article-title":"The \u201cDomino effect\u201d in MASLD: the inflammatory cascade of steatohepatitis","volume":"54","author":"Mladeni\u0107","year":"2024","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jacl.2026.09.007_bib56","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1159\/000527131","article-title":"Obesity in adults: a 2022 adapted clinical practice guideline for Ireland","volume":"15","author":"Breen","year":"2022","journal-title":"Obes Facts"},{"key":"10.1016\/j.jacl.2026.09.007_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13679-025-00637-9","article-title":"Metabolically healthy obesity and metabolic dysfunction-associated steatotic liver disease (MASLD): navigating the controversies in disease development and progression","volume":"14","author":"Koliaki","year":"2025","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.jacl.2026.09.007_bib58","series-title":"Global Health and Aging","year":"2011"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426005180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426005180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:03:57Z","timestamp":1791518637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426005180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":58,"alternative-id":["S1933287426005180"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.09.007","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatty liver index and atherogenic risk determined by lipoprotein particle subclasses: A cross-sectional study of middle- to older-aged adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}